The catheter industry is poised to witness substantial growth from 2025 to 2035, fueled by the development of medical technology, an aging population, and the growing incidence of chronic diseases.
The market is estimated to be valued at USD 14.23 billion in 2025, with a forecasted CAGR of 6.3% during the forecast period. By 2035, the industry will be worth USD 26.32 billion, indicating high growth on account of increasing demand for minimally invasive surgeries and better healthcare infrastructure across the globe.
In 2024, the most notable development was the introduction of silicone-based urinary catheters which offered improved patient comfort and reduced complications associated with urinary catheters including meatitis, urethritis, and trigonitis.
The ability of these catheters to withstand temperature variations and their resistance to various chemicals led to better patient outcomes and lower healthcare costs due to catheter-related infections.
Rising incidences of cancer, cardiovascular diseases and renal diseases are also driving demand for central venous catheters in emerging economies, which has increased significantly.
Manufacturers responded by customizing products to suit the specific needs of these regions and their respective health care challenges. However, the industry struggled to reduce bloodstream infections related to central venous catheters.
As multidrug-resistant organisms resulted in producing infections that could not be treated, prevention and treatment were challenged and required on-going new ideas as well as rigorous infection control implementation.
The increasing prevalence of cardiovascular diseases, urinary disorders and neurological diseases has been driving demand for different types of catheters such as cardiovascular, urinary and neurovascular catheters.
| Metric | Value |
|---|---|
| Industry Size (2025E) | USD 14.23 billion |
| Industry Value (2035F) | USD 26.32 billion |
| CAGR | 6.3% |
Explore FMI!
Book a free demo
Several stakeholders in the field participated in a questionnaire and were asked about their thoughts and viewpoints regarding the performance of the catheter industry during a short survey by Future Market Insights.
Based on these objectives, the data results had a broad consensus that the advanced catheter materials, especially silicone and antimicrobial-coated, reduced infections and improved patient comfort, leading to their increasing adoption.
Participants highlighted the increasing demand for minimally invasive procedures, prompting advancements in catheter design and functionality.
Furthermore, common themes included the importance of regulatory compliance and stringent quality standards as determinants of product development and industry entry.
The other important insight from the survey was the growing investment in research and development for their technological advancements for catheter durability and performance. Industry leaders cited the need for catheters with greater flexibility, biocompatibility, and longevity, particularly for long-term use in chronic disease management.
Stakeholders categorized the emerging industry as major growth regions as healthcare infrastructure and the accessibility of advanced medical technologies have improved in regions such as Asia-Pacific and Latin America.
| Country/Region | Regulatory Impact and Mandatory Certifications |
|---|---|
| European Union (EU) | Medical device manufacturers must comply with the Medical Device Regulation (MDR), ensuring stringent safety and performance standards. Certification under ISO 13485 is essential for quality management. |
| United Kingdom (UK) | The UK enforces its own Medical Device Regulation post-Brexit, requiring compliance with UK MDR. ISO 13485 remains the recognized quality standard for medical devices. |
| United States (USA) | The FDA regulates medical devices under the Quality System Regulation (QSR). Efforts are ongoing to align these standards with ISO 13485 to streamline approvals. |
| Canada | Medical devices must meet the Canadian Medical Device Regulations and obtain ISO 13485 certification, ensuring compliance with quality and safety requirements. |
| India | The CDSCO oversees regulatory approvals for medical devices, making certification mandatory. The Bureau of Indian Standards (BIS) sets additional quality requirements for specific medical products. |
| Japan | Manufacturers must comply with ISO 13485 alongside national quality control standards outlined by the Ministry of Health, Labour and Welfare. |
The global catheter industry is highly competitive, and key players are increasing sector presence by focusing on pricing, innovation, strategic partnerships, and geographic presence.
Big players like Medtronic, Boston Scientific, Abbott Laboratories, and Becton Dickinson & Co. are spending money on research and development to launch a next-generation solution in the catheter industry with better antimicrobial properties, patient comfort, and efficiency.
The price competition in the catheter market is also intense, as players are using cost-effective manufacturing, economies of scale, and competitive pricing models to gain a larger share in key segments such as urinary catheters, vascular access catheters, and central venous catheters.
M&A activity and strategic partnerships are another dominant trend as companies aim to broaden product offerings as well as solidify global distribution networks.
The best companies push to grow by seeking new technology, regulatory approvals, and emerging sectors. Incorporating AI-enhanced technologies in catheter-based therapies, developing antimicrobial and biodegradable catheters, and enhancing material durability.
It includes a key emphasis on expansion into Asia-Pacific, Latin America, and the Middle East, as healthcare investments rise and awareness of catheter-based procedures grows.
Moreover, companies are collaborating with hospitals and health care providers to broaden the product accessibility and facilitate the widespread adoption. Such a shifting environment highlights how fast the industry moves, with firms constantly trying to innovate and stay ahead of the competition.
The industry for catheters worldwide witnessed major developments in 2024, wherein leading players concentrated on innovation, acquisitions, and strategic partnerships to enhance their industry position.
Coloplast held onto its number-one spot with a strong portfolio of both intermittent and Foley catheters, using bulk hospital contracts to maintain its dominance. The company’s growth continued to be spurred by its expansion in self-catheterization products.
Becton Dickinson (BD) captures the second-largest industry share; its portfolio encompasses a wide array of urinary catheters, especially with advanced infection-control solutions. The focus on R&D and product differentiation helped stay ahead of competition. Wellspect Healthcare continued to develop into a strong force in the intermittent catheter segment.
In 2024, Boston Scientific advanced on this by way of next-generation catheterization. Focused on minimally invasive solutions, the company improved patient outcomes and grew its worldwide footprint by aligning with healthcare providers.
It was the reason Teleflex Incorporated increased its industry through acquisitions and new product launches. The company’s focus on the development of ergonomic catheter designs and advanced patient safety features is expected to drive growth in its hospital and home care segments.
These advancements entail a highly competitive catheter industry, whereby major players are looking to maintain their industry share through innovative product offerings, acquisitions, and geographic expansions.
Coloplast
Becton, Dickinson and Company (BD)
Boston Scientific Corporation
Medtronic plc
Teleflex Incorporated
Convatec Group
Hollister Incorporated
B. Braun Melsungen AG
The United States catheter landscape is expected to be highly profitable in the review period. It held a global share of around 35% in 2025. The country will likely register a CAGR of 6.5% during the forecast period.
Some of the key drivers of this strong growth include high prevalence of chronic urological conditions such as aggressive prostate cancer, urinary incontinence, and bladder dysfunction.
More serious one is that the aging population has greatly contributed to this, as the elderly need a greater long-term catheterization to combat these problems.
The USA also has a high volume of surgical patients in a wide range of disciplines, such as urology, gynecology, and oncology, where effective management of urinary function cannot be achieved without the use of Foley catheters.
The catheter industry in the UK is expected to grow at a CAGR of 5.8% from 2025 to 2035. As the population ages and chronic diseases such as cardiovascular diseases and diabetes become more common, catheterization becomes a more common procedure in interventional anatomical cardiovascular procedures.
In the UK, the National Health Service (NHS) distributes catheters to patients, facilitating distribution at low or no cost. Investments in technologies like antimicrobial coatings and hydrophilic-coated catheters have enhanced patient convenience while minimizing the risk of infection, driving further growth of the industry.
The industry is projected to experience robust growth due to the presence of some key manufacturers and a well-established healthcare infrastructure.
The growth of the catheter market in France is attributed to factors such as a growing geriatric population, rising prevalence of chronic urological diseases, and increasing healthcare investments.
France catheter industry is anticipated to have a CAGR of around 5.9% during the forecast period. An increase in life expectancy also expands the demand for sophisticated medical devices that address age-related conditions such as urinary incontinence, kidney disorders, and cardiovascular diseases.
The increased focus on minimally invasive procedures further boosts the utilization of catheter solutions globally in hospitals, clinics, and home healthcare settings. The latest development in catheter technology that provides major advances in the French catheter sector is the launch of innovative catheters, for example, pre-lubricated and antimicrobial-coated catheters.
Such innovations minimize the risk of infection, improve the comfort of patients, and streamline medical procedures.
Germany’s catheter industry is anticipated to have a CAGR of around 6.0% during the forecast period. Germany, as the largest healthcare industry in Europe, also boasts a robust healthcare infrastructure and a large geriatric population, which creates a rising demand for a multitude of catheter devices such as urinary, cardiovascular, and neurovascular catheters. German companies develop and produce high-quality, high-performance catheters according to international standards.
Advancements, including silver-coated and hydrophilic catheters, strives to minimize infection risks while enhancing patient outcomes. It is also located strategically in Europe with efficient distribution towards neighbouring countries, boosting its industry.
These products must comply with stringent EU medical device regulations, ensuring that they are reliable and safe, which in turn strengthens Germany's foothold in the global catheter industry.
Italy is likely to lead the catheter landscape by exhibiting a CAGR of 5.7% from 2025 to 2035. The growing population and the larger number of people suffering from chronic illnesses, such as cardiovascular disease and diabetes, the need for catheterization increases.
Advanced catheter technologies also are adopted in the Italian healthcare system, such as antimicrobial coatings and improved materials that can ensure greater comfort for patients along with less risk of infection.
The segment growth is also supported by government initiatives to enhance healthcare infrastructure and access to medical devices. There are also a few international companies working with local manufacturers to supply high-quality catheter products in Italy.
South Korea is expected to lead the catheter segment by exhibiting a CAGR of 6.8% from 2025 to 2035. The adoption of innovative catheter technologies in the country is influenced by its developed healthcare infrastructure and emphasis on technological innovation.
The demand for catheters for diagnosis and treatment is being supported by the geriatric demographic and the rise in prevalence of chronic diseases such as cardiovascular disorders and diabetes.
Manufacturers in South Korea are working on developing catheters with enhanced biocompatibility and that lead to infection rates that are lower. Also, government initiatives in support of medical device innovation and favourable reimbursement policies further fuel industry growth.
Japan has an aging population and, consequently, a high prevalence of chronic diseases that require catheterization, including urinary incontinence and cardiovascular diseases.
Similarly, Japan's commitment to technological advancement has resulted in high-grade catheters featuring antimicrobial coatings and advanced materials. The increased focus on patient safety and comfort in the healthcare system stimulates the uptake of these sophisticated products.
The partnerships among local and foreign manufacturers increase the number and range of catheter products available in the Japanese industry.
China's catheter industry is projected to grow at a strong CAGR of 5.5% from 2025 to 2035. In 2025, it accounted for approximately 9.7% of the global industry share. The tremendous industry growth is attributed to a large and aged population, the rising prevalence of chronic diseases, and advancements in healthcare infrastructure.
This is due to rising demand for catheters and other medical devices, as the Chinese government is working on providing access to quality healthcare. Domestic manufacturers are adopting advanced technologies at a rapid pace to manufacture cost-effective and high-quality catheters for both domestic and international industry.
In addition, government policies, including tax incentives, subsidies for medical device manufacturers, and increased investments in healthcare infrastructure, make the industry attractive for growth.
The country will likely register a CAGR of 6.2% during the forecast period. These countries have well-established healthcare systems and a greying population that are collectively driving up demand for catheterization procedures.
Including catheters assists in effective management of chronic diseases like diabetes and cardiovascular diseases. Industry growth is driven by the advancement of technologies and the minimization of procedures. Government initiatives further support the catheter industry's growth in these regions to improve healthcare services and accessibility to medical devices.
The catheter industry in India is expected to grow at a CAGR of around 8.5% from 2025 to 2035, driven by increasing cases of chronic diseases like diabetes and cardiovascular disorders.
A growing elderly population and improved healthcare infrastructure in rural and urban areas are also key factors fuelling demand. India’s rise as a medical tourism hub has further boosted industry expansion, with hospitals adopting advanced catheter technologies to meet international standards.
Domestic manufacturers are also focusing on cost-effective solutions, supported by the ‘Make in India’ initiative, which reduces reliance on imports and promotes local production. Overall, India's catheter industry is set for strong growth, backed by government policies, increasing healthcare investments, and rising demand for affordable, high-quality medical devices.
The Catheters product segment consists of ventricular catheters, intrathecal delivery catheters, and ventricular access devices such as Ommaya reservoirs. Technological advancements in catheter design with antimicrobial coatings and minimally invasive catheterization techniques are driving the expansion of this segment.
The use of disposable and single-use catheters drive the industry in technological advancements. In addition, the use of disposable and single-use catheters is also driving the industry, as healthcare providers prioritize infection control and patient safety.
The Indication section relates to the information about medical conditions that require catheterization. Catheters are commonly used in cases of cardiovascular, urological, neurological, and renal diseases.
Chronic conditions, including heart disorders and kidney diseases, are on the rise, directly contributing to the demand for catheters. Moreover, the increasing number of procedures and hospital admissions is also driving the demand for catheters in various medical specialties.
The end user segment includes hospitals, ambulatory surgical centres, home care settings, long-term care facilities, and specialty clinics. Hospitals account for the largest share due to the high number of surgical and emergency procedures requiring catheters.
Ambulatory surgical centres are also key consumers as minimally invasive procedures grow in popularity. Home care settings are witnessing growing demand, especially for self-catheterization, as more patients opt for at-home management of chronic conditions.
Long-term care facilities, such as nursing homes, rely on catheters for elderly patients requiring extended care. Specialty clinics and outpatient centres are emerging as notable users, particularly in neurological, cardiovascular, and urological treatments, as accessibility to outpatient care improves.
| 2020 to 2024 (Past) | 2025 to 2035 (Future Outlook) |
|---|---|
| Industry Growth: Steady growth driven by rising chronic diseases, aging populations, and increased hospital admissions. | Industry Growth: Expected to continue at a stable CAGR of 8.5%, with a focus on technological advancements and home healthcare expansion. |
| Key Drivers: COVID-19 pandemic boosted demand for urinary and vascular catheters in ICU settings. Aging populations and increased surgical procedures also contributed to industry growth. | Key Drivers: Increasing prevalence of chronic diseases (e.g., kidney disorders, cardiovascular diseases) and the rise of minimally invasive procedures will sustain demand. |
| Technological Advancements: Smart catheters with antimicrobial coatings, self-lubricating technology, and remote monitoring capabilities gained traction. | Technological Advancements: AI-driven and sensor-enabled catheters for real-time monitoring are expected to dominate. Biodegradable and eco-friendly materials may gain popularity. |
| Regulatory Landscape: Stricter sterilization guidelines and safety regulations emerged post-pandemic, increasing compliance costs for manufacturers. | Regulatory Landscape: Governments will likely continue enforcing stricter compliance, with an increased focus on sustainability and patient safety. |
| End-User Trends: Hospitals remained the dominant segment, but home healthcare saw increasing adoption, especially for intermittent catheterization. | End-User Trends: Home healthcare and ambulatory settings will gain more prominence due to patient preference for convenience and cost-effectiveness. |
The catheter industry is a part of the medical devices industry and is segmented into healthcare consumables and disposables. It is an essential part of the overall healthcare system, affecting both hospitals and home health care.
Due to its critical role in efficiently in delivering cares to patient demand for catheters is relatively inelastic, making it a defensive industry that is less sensitive to economic pullbacks than discretionary sectors.
Demand for catheters is linked to global healthcare expenditure, demographic trends, and technology. The aging population in developed economies such as the USA, Japan, and Western Europe is creating strong demand due to elderly patients being more susceptible to chronic illness requiring catheterization.
At the same time, increasing middle-class incomes in the fast-growing economies of India and China are making healthcare more widely available, driving catheter usage.
Government policies regarding insurance coverage and its scope are also some of the most influential factors that drive the industry growth. There is a good reimbursement system for catheters in Europe, so we can talk about a steady demand in the EU, unlike the USA, where the entire healthcare system is still private, and, there are always new price wars.
In countries with privatized healthcare, cost and reimbursement policies may influence adoption rates. The industry also faces cost pressures from fluctuations in raw materials, inflation, and supply chain disruptions. To stay profitable, businesses are investing in increased automation, environmentally friendly alternatives, and digital integration.
The catheter landscape has significant growth potential, particularly in developing economies such as India, China, and Southeast Asia, where there is a growing investment in healthcare expenditure and the enhancement of medical infrastructure to improve services.
Local manufacturing within the country will enable companies to increase their presence in the segment, along with reducing production costs and import restrictions. Furthermore, the rising prevalence of chronic diseases such as cardiovascular disease, urinary incontinence, and neurological disorders is driving the demand for advanced catheters.
In addition, the rise of aging populations all around the world is leading to a push for home healthcare, which creates opportunities for the development of user-friendly, self-insertable catheters, making uniquely flexible catheters even more convenient for patients.
The investment in biocompatible materials and innovations focused on sustainability can give companies a competitive edge. Regulatory compliance is crucial due to increasingly stringent policies from the FDA, EU MDR, and Asian authorities.
Firms are advised to proactively obtain their CE Mark and ISO 13485 certifications. Smart technology integration and remote patient monitoring are transforming the industry. Product companies are incorporating smart technology into their devices and work with telemedicine providers for remote patient monitoring, which can drive up product sales.
Automation and localized sourcing will improve cost efficiencies and help companies stay competitive in this evolving industry.
Rising chronic diseases, aging populations, and advancements in minimally invasive procedures are key drivers.
Boston Scientific, Medtronic, Coloplast, and BD are among the top players focusing on innovation.
Regulations like EU MDR and FDA guidelines ensure safety but can affect pricing and approval timelines.
Antimicrobial coatings, hydrophilic surfaces, and sensor-enabled designs enhance safety and comfort.
North America and Europe lead, while Asia-Pacific, especially China and India, is growing rapidly.
Urinary Catheters, Intravenous Catheters, Short Peripheral IV Catheter, Integrated/Closed PIVC, Central Venous Catheters, Hemodialysis Catheters
Urinary Incontinence, Urethral Stricture, Chronic Obstruction, Neurogenic Bladder, Enlarged Prostate Gland/BPH, Prostate Cancer, Acute Kidney Injury, Others
Hospitals, Dialysis Centers, Long-term Care Facilities, Ambulatory Surgical Centers, Home Care
North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East
Hyperammonemia Treatment Market Trends – Growth & Therapeutic Advances 2025 to 2035
Veterinary Auto-Immune Therapeutics Market Growth - Trends & Forecast 2025 to 2035
Radial Compression Devices Market Growth - Trends & Forecast 2025 to 2035
Digital Telepathology Market is segmented by Application and End User from 2025 to 2035
Generalized Myasthenia Gravis Management Market - Growth & Treatment Advances 2025 to 2035
Hutchinson-Gilford Progeria Syndrome Market Growth – Innovations & Therapies 2025 to 2035
Catheter Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
